A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of GSK2556286 in Healthy Adult Participants

Trial Identifier:	210035
Sponsor:	GlaxoSmithKline
Collaborator:	Not applicable
Start Date:	October 2020
Primary Completion Date:	November 2024
Study Completion Date:	November 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Netherlands	GRONINGEN, Netherlands, 9713 AG
United Kingdom	Cambridge, United Kingdom, CB2 2GG

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.